1/7 The pharmaceutical industry have managed to turn a drug, which in the opinion of many experts should never have been approved by the regulatory authorities, into the biggest financial success they have ever enjoyed.
2/7 For the pharmaceutical companies, profit is the driver and health is a secondary issue. They saw in statins the opportunity to produce what is in financial terms the perfect drug. It can be prescribed to a significant percentage of the public who are NOT ill
3/7 but ‘AT RISK’, it does not provide a cure and users must take it for the rest of their lives to benefit from its alleged reduction in cardiovascular disease and strokes.
In a way statins are used like a vaccine and given to many people who are perfectly well
In a way statins are used like a vaccine and given to many people who are perfectly well
4/7 on the basis that it will prevent them from becoming ill in the future. No one knows which persons among those ‘at risk’ will benefit and which of them will simply be exposed to the significant adverse effects with no benefit at all. In these circumstances it is absolutely
5/7 essential to ensure that the clinical trials which show the safety and efficacy of the drug are rigorously undertaken with the results known and accepted by all relevant experts as well as Drs and patients alike. Instead of exercising the highest level of due diligence in
6/7 carrying out these trials, the drug companies have WITHHELD raw data from which the trial results were derived so that independent experts cannot verify the conclusions from the trials. In addition, the body which oversees the publication of trial results -
7/7 The Clinical Trial Service Unit, has admitted receiving £268 million from pharma companies over the past 20 years, which raises major concerns about the extent to which their work is carried out under the influence of the drug companies. The system is rotten to the core !
